Results 191 to 200 of about 401,321 (268)

The global burden and trends of cutaneous leishmaniasis from 1990 to 2021 with projections to 2036: a population-based study. [PDF]

J Health Popul Nutr
Li G, Yue X, Lu Y, Zhang C.
europepmc   +1 more source

The study of cells using scanning force microscopy [PDF]

, 2011
Eley, AR, Garcia, ALM, Geoghegan, M, Hall, AR, Rogers, ME, Rolfe, SA   +5 more
core  

Cutaneous leishmaniasis of the nose evaluated with confocal microscopy successfully treated with topical 5% imiquimod. [PDF]

JAAD Case Rep
Di Guardo A, Didona B, Ambrosio L, Ricci F, Panebianco A, Di Lella G, Abeni D, Fania L.   +7 more
europepmc   +1 more source

Comparison of meglumine antimoniate versus miltefosine in the treatment of new world cutaneous leishmaniasis: a systematic review and meta-analysis. [PDF]

An Bras Dermatol
Vieira ACP, Lins FC, Baquião AC.
europepmc   +1 more source

From Abroad to Appalachia: A case report of cutaneous leishmaniasis in central Pennsylvania. [PDF]

JAAD Case Rep
Salmen N, Metellus R, Lim O, Pandya A, Horissian M.   +4 more
europepmc   +1 more source

Platelet DKK1 promotes tolerogenic dendritic cells and non-healing responses in cutaneous leishmaniasis. [PDF]

iScience
Ihedioha OC, Sivakoses A, Marcarian HQ, Sajeev M, McMahon-Pratt D, Bothwell ALM.   +5 more
europepmc   +1 more source

Effects of cutaneous leishmaniasis on health-related quality of life: A longitudinal approach. [PDF]

PLoS One
Galvão EL, Carvalho JP, Machado de Assis TS, Cota G, Silva SN.   +4 more
europepmc   +1 more source

Indazole Derivatives Against Murine Cutaneous Leishmaniasis. [PDF]

Pharmaceuticals (Basel)
Mollineda-Diogo N, Pérez-Castillo Y, Sifontes-Rodríguez S, Marrero-Chang O, Meneses-Marcel A, Escalona-Montaño AR, Aguirre-García MM, Espinosa-Buitrago T, Morales-Moreno Y, Arán-Redó V.   +9 more
europepmc   +1 more source